Amentum is trading at $20.48, down -4.63% after JPMorgan cut its price target to $26 from $31 while maintaining a Neutral rating.
- JPMorgan cited near-term headwinds outweighing Amentumβs longer-term opportunities, reinforcing investor caution.
- The decline follows earlier post-earnings pressure tied to slower revenue growth and execution concerns.
- The broader market is only modestly weaker, making the analyst action the clearest catalyst for August 17, 2026.